Lilly's Weight-loss Pill Wins Us Approval, Sets Up Next Battle with Rival Novo Nordisk
The US Food and Drug Administration (FDA) has approved Eli Lilly's weight-loss pill, Zepbound, making it the first oral weight-loss drug to be approved in the US in five years. The approval comes after the FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 13-2 in favor of the medicat...
